Dr.
Polack Seeks an Antibiotic
Some 55 million poor and disabled Americans are covered by
Medicaid. With an annual price tag topping $300 billion, it's among the
biggest government programs around.
It's also a lucrative business for some private companies
that act as middlemen between the government and patients. Instead of
directly paying the bills when a Medicaid patient goes to the doctor,
state governments increasingly outsource the job to private contractors.
More than one in three Medicaid beneficiaries now receive care through a
private insurer.
The potential gains are big. Four years ago, a
private-equity fund in which George Soros was the largest investor took a
70% stake in WellCare Health Plans Inc., a leading Medicaid
health-maintenance organization. The fund finished cashing out the stake
this August, bringing in a total of $870 million for an investment that
originally cost $220 million.
The companies are growing fast. Centene boasts nearly 1.2
million members and posted $1.5 billion in revenue last year. That
compares with 142,000 members and $200 million in revenue six years
earlier.
With the growth has come criticism from some doctors and
patients who accuse Medicaid HMOs of scrimping on care. Even as they
restrict medical tests and use of prescription drugs, the companies spend
the money they get from states on items that don't have an obvious
connection to patients. Centene has funded a multimillion-dollar arts
center in St. Louis and paid to put its name on stadiums in Montana and
Missouri. The HMOs are also big donors to political campaigns.
Executives say their profits are justly earned and don't
come at patients' expense. Traditional Medicaid is a fee-for-service
program: The government pays each medical bill the patient racks up, with
little or no effort to manage the costs. Medicaid HMOs, like other HMOs,
seek to save money by eliminating unnecessary care and paying for
preventive treatments. Centene Chief Executive Michael Neidorff says the
company sometimes gives free child-safety car seats to pregnant women who
attend all of their prenatal exams. "We save millions" by preventing
premature births, he says.
Mr. Neidorff earned $1.85 million in salary and bonus last
year and as of the end of last year held restricted stock valued at $26
million. The company also recorded $135,547 last year in compensation for
Mr. Neidorff representing the value of personal trips he took on the
corporate jet, a Bombardier Challenger that features an espresso machine
on board, according to the lease agreement.
Centene spokesman Robert Schenk declined to say how much
the company pays to lease the jet. He said the jet is needed because many
of Centene's operations are hard to reach by commercial carriers, and the
company's board requires Mr. Neidorff to use corporate transportation even
on personal travel to ensure that he is secure and accessible.
Centene's business is managing the care of patients such as
Melissa Bishop, 39 years old, of Phillipsburg, N.J. When she needed
radiation for cancer near her pancreas this summer, she called Centene,
her Medicaid HMO. She says she tried three facilities suggested by the
company, but none of them were part of Centene's plan. "I was going round
and round and round," says Ms. Bishop. "I was getting so aggravated."
After she got an appointment at a fourth place, an
administrator there told her it didn't accept her plan either. The
administrator, Barbara Tofani of Hunterdon Regional Cancer Center in
Flemington, N.J., says she called a dozen other centers in the region and
struck out every time. Finally, Ms. Tofani called Centene and negotiated
an ad-hoc deal to cover Ms. Bishop's treatment, although Ms. Tofani says
the center will be lucky to break even.
Andrew Greenberg, Ms. Bishop's radiation oncologist, says
that if it hadn't been for the special effort, "Melissa would have gotten
lost in the system." Centene didn't provide comment on Ms. Bishop's
case.
Each state runs its own Medicaid program but the majority
of funding generally comes from the federal government. When states sign
up HMOs to manage care, they often calculate what they would spend on
Medicaid patients directly and pay the HMOs a per-patient premium below
that amount. Florida, for instance, sets its HMO premium rates about 8%
below what it would cost the state. WellCare, a big operator in Florida,
says it saves the state $75 million a year. HMOs have an incentive to keep
their costs under the premium because they keep the difference as
profit.
After several years of spiraling growth in Medicaid costs,
there's some evidence that the tide is turning, although it's unclear how
much HMOs have contributed. Total Medicaid spending grew in fiscal 2006 by
just 2.8%, according to a report last month by the Kaiser Commission on
Medicaid and the Uninsured. That was the lowest rate of growth since 1996.
The commission said that for the first time in years many states aren't
feeling pressure to cut people off Medicaid rolls.
Are Medicaid HMOs slashing necessary care to achieve cost
savings and raise profits? Yes, says Jerry Flanagan, health-care policy
director of a California group that wants to stop state governments from
moving Medicaid beneficiaries into private managed care. "What's good for
shareholders is bad for patients," he says. "What's really happening is
we're giving less money for far, far fewer services."
Private companies "deliver a good-quality product at a
reasonable price," counters Ruben Jose King-Shaw Jr., a former top federal
Medicaid and Medicare official who joined WellCare's board in 2003. He
notes that states often require private HMOs to achieve high rates of
vaccination and other quality standards that weren't met when bureaucrats
did all the work. Mr. King-Shaw, whose final annual salary in government
was $142,500, has sold WellCare shares for $1.8 million. He owns shares
and options valued at an additional $1.5 million. "You only do well in
health care if you deliver value," he says.
States began experimenting with using managed care for
Medicaid patients in the early 1980s, and the idea took off in the 1990s.
Now many states are moving aggressively to put more Medicaid patients in
HMOs. Last month, Ohio chose the winning bidders to provide Medicaid HMO
services to 120,000 of the state's aged, blind and disabled population --
a group that traditionally hasn't been placed in HMOs.
When states run their own Medicaid programs, they spend on
average 4% to 6% on administrative costs, according to Martha Roherty,
director of the National Association of State Medicaid Directors. The rest
-- 94% to 96% -- goes to paying for medical care. At Medicaid HMOs, only
80% to 85% of premium dollars generally go for medical costs. The rest
covers other costs -- including executive compensation, entertainment and
political contributions -- or becomes profit for shareholders.
States monitor the profit margins of Medicaid HMOs, which
are generally reported as 5% or less. State officials say that with such a
thin margin there's little room for further savings, although a review in
New Jersey questioned whether one HMO was overcharging its subsidiary in
the state for services. That could make the subsidiary's profits look
lower.
While they spend fewer dollars on medical care, companies
say they are more efficient and improve the health of patients. Elizabeth
Douglas of Chicago says her 11-year-old son has kept up on his
immunizations thanks to a WellCare program that gives her a free ride to
the doctor's office.
Some patients and doctors have a different view. Kuldeep
Singh, an internist in Valdosta, Ga., says that when Georgia began to move
more than a million Medicaid recipients into HMOs this year, he suddenly
faced hurdles not imposed by regular Medicaid. Recently, he says, one of
his assistants had to wait on hold to get approval from WellCare for a
hospital chest X-ray on a patient suspected of having pneumonia. "It was
ridiculous," says Dr. Singh. A spokesman for WellCare says it sometimes
requires such approval because hospital-based X-rays cost two to three
times as much as those done in a doctor's office or imaging center.
Many doctors refuse to take patients in Medicaid HMOs
because reimbursements are so low. (The same problem occurs in traditional
Medicaid.) Noha Polack, a pediatrician in Union City, N.J., has an
arrangement under which Centene pays her a fixed monthly sum per child to
handle basic medical needs. Until a few months ago, that sum was $11.50
per month, equal to $138 a year -- about half of what other Medicaid
insurers pay, says Dr. Polack. A child who had a few colds or scrapes
during a year would quickly put her in the red.
Dr. Polack threatened to drop all her Centene patients and
recently got a raise -- the amount of which is confidential, she says --
but she still stopped accepting new Centene patients.
The HMO is stingy about drugs that others approve with
little question, says Dr. Polack, naming the antibiotic Ceftin as an
example. "Many times we have to make treatment decisions not depending on
what would be best for the patient but what the patient can afford," she
says. While she could ask for an exception to use Ceftin, "they are so
notorious for not getting back to you" and there's little time when a
child has an infection, she says.
Vickie Vickers, a 39-year-old Trenton, N.J., single mother
on disability and Medicaid, learned about the difficulty of finding a
doctor this year. She hurt her hand on Mother's Day while stooping to pick
up playing cards that fell on the floor. She went to the hospital for a
temporary cast but spent weeks with Centene trying to find an orthopedic
doctor.
She finally found one an hour away. She says the
orthopedist told her she needed an MRI or CT scan, but Centene wouldn't
approve it. It took until late June for an orthopedist to fit her with a
splint with metal bars.
Ms. Vickers rents a house in a run-down part of Trenton
with a rusty fence outside and a leaky roof that has caused big water
stains in the attic, bedroom, bathroom and kitchen. She wishes the old
Medicaid were back because in the 1990s "you didn't have to call 50
doctors" to get an appointment.
Centene didn't provide comment on the complaints by Dr.
Polack and Ms. Vickers.
Research on the quality of care in Medicaid HMOs is thin. A
study of infant health last year by researchers at the University of
Illinois-Chicago and the Urban Institute found that Medicaid managed care
was correlated with a slight increase in inadequate prenatal care in some
women but in general showed little difference from traditional
Medicaid.
While some doctors and patients complain of Centene's
stinginess, the company has been generous in regions where it has offices.
Centene last year was the biggest donor for a $9.5 million renovation of
an arts building in St. Louis, now called the Centene Center for Arts and
Education, according to a spokeswoman for the center. The company paid
$200,000 last year for the naming rights of a minor-league baseball
stadium in Montana, where Centene employs 100 claims processors but
doesn't have Medicaid clients. Centene also pledged $400,000 this year to
the school district in Clayton, Mo., where the company has its
headquarters, to rename the district's stadium.
Cynthia Schultz, director of the Great Falls International
Airport in Montana, says Mr. Neidorff, the Centene CEO, once walked
through the airport and heard that it couldn't afford artwork. Centene
then commissioned and donated a $7,000 welded-metal sculpture of an eagle
with a 16-foot wingspan that now hangs prominently in the airport, she
says. The company confirmed the donation. "It's a great gift from someone
who doesn't even live here," says Ms. Schultz.
Mr. Schenk, the Centene spokesman, said the donations show
Centene is a "responsible and publicly focused corporation" and they help
make the communities better places to live.
A few big U.S. insurers that serve large employers,
including UnitedHealth Group and WellPoint Inc., also
compete in the Medicaid HMO market. Many others don't. Medicaid HMOs
assemble doctor networks in places with many people on Medicaid -- such as
big cities and poor rural areas -- and deal with a single kind of
customer, state governments. Those skills "are importantly different than
what most commercial insurers have," says John W. Rowe, the former chief
executive at Aetna Inc. and now a professor at Columbia University.
Medicaid HMOs have donated to candidates in state political
races who support their existence. In 2005, five WellCare subsidiaries
together donated $125,000 to Illinois Gov. Rod Blagojevich, a Democrat who
won re-election this month. WellCare has 92,000 members in Illinois.
This year, 20 WellCare subsidiaries each donated the legal
maximum of $500 to the campaign of Republican Tom Lee, who was narrowly
defeated in his bid to become chief financial officer of Florida,
WellCare's biggest market. WellCare donated $34,000 to the Republican
Governors Association this year and contributed $100,000 to President
Bush's second inaugural festivities in 2005.
"I call a governor, I usually get a call back within 24 to
48 hours," says Centene's Mr. Neidorff.
States keep track of the finances of Medicaid HMOs to
ensure that the HMOs are spending a sufficient part of their revenue on
medical costs. However, the numbers are subject to interpretation. A
review of Centene's New Jersey subsidiary in 2004, by a unit of Marsh
& McLennan Cos., said hundreds of thousands of dollars that
Centene counted as medical costs should have been considered
administrative costs.
The report also questioned cases where Centene's New Jersey
subsidiary pays a national Centene subsidiary for specialized services
such as mental-health or a nurse hotline. It said the New Jersey
subsidiary was paying an above-market rate for some of these services.
That would tend to increase the state subsidiary's medical costs and
reduce its profit, without affecting the bottom line of Centene as a
whole. Mr. Schenk of Centene declined to discuss the report in detail but
said Centene has used the findings "to strengthen its operational
efficiencies."
In Illinois, the state and the Justice Department asserted
in a lawsuit that Amerigroup spent only $131 million on medical care from
2000 to 2004 despite taking in $243 million from the state. The lawsuit
accused Amerigroup of fraudulently trying to exclude pregnant and sick
patients to reduce its medical costs. A jury in Illinois state court
agreed last month, finding Amerigroup liable to the government for $144
million. Internal Amerigroup emails filed in court show managers
contemplated disciplinary action for employees who signed up women in the
third trimester.
Amerigroup said it will appeal. The company says it
discouraged transfers by pregnant women so their care wouldn't be
disrupted. A spokesman said the figures in the suit are "extremely
misleading," in part because they don't account for preventive health
programs.
---- Raymund
Flandez contributed to this article.
Write to Barbara Martinez at Barbara.Martinez@wsj.com1